Klow Blend (GHK-Cu, KPV, BPC-157, TB-500) Dosage Guide, Benefits & Side Effects

Klow Blend (GHK-Cu, KPV, BPC-157, TB-500) Dosage Guide, Benefits & Side Effects

This four-peptide stack of GHK-Cu, KPV, BPC-157, and TB-500 targets healing, inflammation, and skin regeneration across multiple pathways.

Chemical Makeup

18

Amino Acids

Klow Blend (GHK-Cu, KPV, BPC-157, TB-500)

Gly

Position 1

His

Position 2

Lys

Position 3

Cys

Position 4

Sec

Position 5

Thr

Position 6

Asx

Position 7

Position 8

Pro

Position 9

Position 10

Position 11

Position 12

Val

Position 13

Arg

Position 14

Ala

Position 15

Position 16

Ile

Position 17

Pyl

Position 18

As seen on

Klow Blend (GHK-Cu, KPV, BPC-157, TB-500) Dosage Guide for Longevity & Anti-AgingKlow Blend (GHK-Cu, KPV, BPC-157, TB-500) Dosage Calculator

This blend combines GHK-Cu, KPV, BPC-157, and TB-500 to support skin health and general tissue repair. How much you take depends on the amount of GHK-Cu in the specific product.

Vial size

35 mg

Bacteriostatic water

3–5 mL

Dosing

1–3 mg

Frequency

5 days on / 2 days off

Cycle

6–8 weeks

Benefit

Longevity & Anti-Aging

What is Klow Blend (GHK-Cu, KPV, BPC-157, TB-500)?

KLOW is a blend of four well-known healing peptides (KPV, GHK-Cu, BPC-157, and TB-500) combined into one product to support tissue repair from several different angles at once. Each individual ingredient has its own research backing for healing, inflammation, and skin health, but the combination itself hasn't been formally tested as a single product. It's used in research and wellness settings for comprehensive support of healing, inflammation, and tissue repair.

Healing

Research targets include tissue repair, wound healing, and recovery from injury.

Skin

Research targets include collagen production, skin elasticity, and hair follicle health.

klow

Is Klow Blend (GHK-Cu, KPV, BPC-157, TB-500) FDA approved?

Klow Blend (GHK-Cu, KPV, BPC-157, TB-500) is not an FDA-approved drug. It is intended for research purposes only and is not approved for human consumption, diagnostic, or therapeutic use.

Research Use Only

Klow Blend (GHK-Cu, KPV, BPC-157, TB-500) has not been evaluated by the FDA for safety or efficacy in humans.

No Clinical Oversight

Not manufactured under FDA-regulated quality or clinical standards.

Unregulated Sourcing

Purity, dosing, and sourcing are not verified through FDA testing or oversight.

Our top-rated vendor

View all vendors

Our rankings are based solely on third-party lab testing rigor, COA transparency, and pricing — no paid placements, no affiliate influence. We update this list as new data comes in.

Based on current scores, this vendor ranks highest across those criteria.

Protide Health

#1 Rated Research Peptide Supplier

How Does Klow Blend (GHK-Cu, KPV, BPC-157, TB-500) Work?

Each of the four peptides in this blend tackles healing differently: one drives new blood vessel growth and healing signals, another helps cells physically move to the injury site, a third calms inflammatory signaling, and the fourth boosts collagen production. Together, they aim to cover inflammation, blood flow, and tissue rebuilding all at once.

Four angles of repair

Each of the four peptides tackles healing a different way.

Vessels & movement

Some drive new blood vessel growth; others help cells physically move to the injury.

Inflammation & collagen

The remaining two calm inflammation and boost collagen production.

Klow Blend (GHK-Cu, KPV, BPC-157, TB-500) Targeted areas

How to reconstitute Klow Blend (GHK-Cu, KPV, BPC-157, TB-500)

The materials you'll need and step-by-step instructions for safely mixing Klow Blend (GHK-Cu, KPV, BPC-157, TB-500) with bacteriostatic water.

Materials needed

Your Klow Blend (GHK-Cu, KPV, BPC-157, TB-500) vial (lyophilized)

Alcohol swabs

Bacteriostatic sterile water

3 mL syringes (Luer Lock tip)

25G or 27G needles (Luer Lock). Other gauges may also be acceptable.

Sharps container (optional)

Remove the caps

Sanitize the rubber stoppers

Attach the needle

Draw the bac water

Pull back on the plunger to draw your desired volume of bacteriostatic water. If you overfill, just push the excess back in until you reach the right marker on the syringe.

Insert the needle into the Klow Blend (GHK-Cu, KPV, BPC-157, TB-500) vial

With the bac water in your syringe, insert the needle into the Klow Blend (GHK-Cu, KPV, BPC-157, TB-500) vial at a slight angle to avoid pressure buildup.

Release the water gently

Let the water run gently down the side of the vial. Don't inject it forcefully.

Swirl to dissolve

Avoid shaking. Gently swirl, flip, and roll the vial to dissolve the powder.

Check for full dissolution

Cap, dispose, and store

How to Store Klow Blend (GHK-Cu, KPV, BPC-157, TB-500)

Freeze the dry powder. Once mixed with 3mL of bacteriostatic water, refrigerate and use within about a month, avoiding repeated freezing and thawing.

Lyophilized Storage

-20°C.

Reconstituted Storage

With 3.0 mL bacteriostatic water, 2–8°C for up to 28 days.

Handling Notes

Avoid freeze-thaw cycles.

What Are the Benefits of Klow Blend (GHK-Cu, KPV, BPC-157, TB-500)?

What research says it may help with, and how it works in the body.

primary applications

Combines several healing actions that work together to support tissue repair from multiple angles.

Combines multiple peptides into one injection, so users get several benefits without multiple shots.

Encourages the body to produce more collagen and supports overall tissue regeneration.

Tends to be gentler and easier to tolerate than the GLOW blend, thanks to the KPV component.

What Are the Side Effects of Klow Blend (GHK-Cu, KPV, BPC-157, TB-500)?

Who should avoid it, warning signs to watch for, and what to know before combining it with other compounds.

Who Should Avoid It

No safety studies on four-peptide combination

Long-term effects completely unknown

FDA has not approved any component for therapeutic use

Stop Right Away If You Notice

Severe injection site reactions or infection

Allergic reactions (rash, difficulty breathing)

Unusual fatigue or weakness

Signs of copper toxicity (nausea, jaundice)

Worsening of underlying conditions

Milder Signs to Watch For

Klow Blend (GHK-Cu, KPV, BPC-157, TB-500) contains these peptides

The individual peptides blended together to make Klow Blend (GHK-Cu, KPV, BPC-157, TB-500).

bpc

Longevity

BPC-157

Preclinical

ghk

GHK-Cu

Experimental

kpv

Immunity

KPV

tb5

TB-500

How Long Should a Klow Blend (GHK-Cu, KPV, BPC-157, TB-500) Cycle Last?

This breaks down how long a typical Klow Blend (GHK-Cu, KPV, BPC-157, TB-500) cycle runs and what research suggests happens at each stage. Research shows that staying on a peptide continuously, without a break, may make it less effective over time.

That's why most research protocols build in a break between cycles, often called a washout period, to let the body reset before starting again.

Related peptides

Metabolic

mot

MOTS-c

Phase 1

Weight

maz

Mazdutide

Approved

nad

NAD+

orf

Orforglipron

Fda Approved

Cheat Sheets Featuring Klow Blend (GHK-Cu, KPV, BPC-157, TB-500)

See how Klow Blend (GHK-Cu, KPV, BPC-157, TB-500) fits into a broader research stack with these free downloadable cheat sheets. Each one includes reference dose ranges, dosing frequency, and half-life for every peptide it covers. For research purposes only.

18 peptides

42 peptides

78 peptides

7 peptides

Browse user-created protocols

Real protocols from the community that include Klow Blend (GHK-Cu, KPV, BPC-157, TB-500)

Ascension Stack

Nick

GLP-3

Klow Blend (GHK-Cu, KPV, BPC-157, TB-500) Research References

It is a preclinical compound

Klow Blend (GHK-Cu, KPV, BPC-157, TB-500) is a preclinical compound

Small pilot showed 10 of 12 patients achieved complete symptom resolution in interstitial cystitis

n.d.

GHK-Cu demonstrates wound healing, anti-aging, and gene modulation effects in isolation

Frequently Asked Questions About Klow Blend (GHK-Cu, KPV, BPC-157, TB-500)

Straight answers on reconstitution, dosing, and safety, everything you need to research with confidence. For research reference only.

What is the Klow Blend and what does each peptide do?

Klow is a four-peptide research combination that pairs GHK-Cu (a copper-binding peptide studied for skin remodeling and collagen/connective-tissue effects) with KPV (a tripeptide studied for anti-inflammatory and gut-related effects), BPC-157 (studied in animal models for soft-tissue and gut healing), and TB-500, a synthetic fragment of thymosin beta-4 studied for cell migration and systemic tissue repair. The idea behind combining them is to pair a broad tissue-repair effect (BPC-157, TB-500) with an anti-inflammatory component (KPV) and a skin/collagen-supporting component (GHK-Cu). This blend has not itself been studied in published clinical trials — the rationale is based on research on the individual peptides, not on the combination as a whole.

What is the typical vial composition and how is it reconstituted?

Vendors most commonly sell Klow as an 80 mg vial containing 50 mg GHK-Cu and 10 mg each of KPV, BPC-157, and TB-500, though ratios vary by supplier. A common approach is to reconstitute with 2-3 mL of bacteriostatic water, swirling gently rather than shaking to avoid damaging the peptides. After mixing, the solution is generally kept refrigerated (or frozen in single-use aliquots for longer storage) and used within about 2-4 weeks; unreconstituted lyophilized powder is more stable and can be stored per the supplier's instructions until mixed.

What dosing protocols are commonly discussed for Klow?

Discussions in the research community generally describe daily or every-other-day subcutaneous administration, with total blend doses in roughly the 250 mcg-2 mg range depending on how the vial is diluted. When broken out by component, commonly cited reference doses are about 300-500 mcg/day each for BPC-157 and KPV, 1-2 mg/day for GHK-Cu, and TB-500 dosed less frequently (e.g., 2x/week during an initial "loading" phase, then weekly for maintenance) because of its longer-lasting effects. Protocols are often run for 8-12 weeks followed by a break. These figures come from research/vendor dosing guides, not from clinical prescribing information, and have not been validated in controlled human trials.

How is Klow injected, and can the peptides be combined in one syringe?

Most protocols describe subcutaneous injection, with sites rotated between the abdomen, thighs, and upper arms to reduce irritation. Since Klow is sold pre-blended, all four peptides are typically injected together in a single shot; some users report combining KPV and BPC-157 in the same syringe when dosing peptides separately. As with any injectable research compound, sterile technique and single-use needles/aliquots are recommended to reduce contamination risk.

What side effects are reported with Klow?

The most commonly reported issues are injection-site reactions — redness, mild swelling, or tenderness — occurring in an estimated 15-20% of users and usually resolving within 24-48 hours. Mild gastrointestinal symptoms such as nausea or cramping have been reported in under 10% of cases, typically early in a protocol. Some users report dose-dependent fatigue or lethargy, more often attributed to higher TB-500 doses. These reports come from anecdotal/vendor sources rather than controlled trials, so the true frequency and severity of side effects in humans is not well established.

How is Klow different from the GLOW stack?

GLOW is a related three-peptide blend containing the same GHK-Cu, BPC-157, and TB-500 combination but without KPV. Klow adds KPV specifically for its anti-inflammatory and gut-related research profile, making Klow the broader-scope option of the two when inflammation or gut support is a focus, while GLOW is marketed more narrowly around skin and tissue regeneration.

Is the Klow Blend approved for human use?

No. Klow and its component peptides are sold by research chemical suppliers labeled for laboratory/research use only, and none are FDA-approved for human therapeutic use. No published clinical trials have evaluated the four-peptide combination itself. Anyone considering use should be aware of the legal and safety uncertainty involved and should consult a qualified medical professional rather than relying on vendor or forum claims.

How long does it take to notice effects from Klow?

Anecdotal reports vary widely and are not clinically verified, but commonly cited timelines describe subtle changes (e.g., reduced inflammation or perceived energy shifts) within the first 1-2 weeks, more noticeable recovery or mobility improvements around 2-4 weeks, and skin/tissue-related changes such as texture or elasticity taking 4-12 weeks of consistent use. These timeframes come from user and vendor reports rather than controlled studies, so actual results (if any) will vary and are not guaranteed.